The Penn-StARR Program for Research in Residency

Penn-StARR 住院医师研究计划

基本信息

  • 批准号:
    10321397
  • 负责人:
  • 金额:
    $ 34.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Summary To address the widely recognized decline in the physician-scientist workforce, new approaches are needed to recruit talented physicians to pursue research as an integral part of their medical training and their future careers. The Stimulating Access to Research in Residency (StARR) initiative will provide a new point of access to research by accelerating the entry of residents into meaningful research pursuits during residency. This bold initiative will engender, and require, a substantial change in graduate medical education. Here we propose the University of Pennsylvania (Penn)-StARR program, which will tap into a talented and highly motivated pool of diverse residents in Internal Medicine, Family Medicine, Pathology, and Pediatrics. The Penn-StARR program will provide opportunities for these residents to pursue mentored research on topics within the mission of the National Heart, Lung, and Blood Institute (NHLBI). The program will take advantage of a thriving and interactive physician-scientist community that has benefitted from a strong institutional commitment to training, recruitment, and advancement of physician-scientists, particularly those from groups underrepresented in the biomedical sciences. Penn-StaRR will become an anchor for a larger institutional effort to support physician- scientist development and careers. The Penn-StARR program will uniquely provide access to research in residency for 3 residents per year to pursue 12 months of focused research integrated with clinical training and starting as early as possible while maintaining the clinical training required for specialty board certification. The unique features of the Penn-StARR program are: the outstanding, diverse, and motivated resident pool; an existing demand from residents for training for research careers; strong institutional support for physician- scientist training that is evident in the infrastructure, programs, and momentum for physician-scientist training already in place; institutional commitment to support a slot beyond those funded through NHLBI; an outstanding faculty representing diverse areas of research relevant to NHLBI; and a fully integrated campus with an exceptionally interactive research environment across departments and institutions.
总结

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours.
  • DOI:
    10.1186/s13073-023-01219-x
  • 发表时间:
    2023-09-07
  • 期刊:
  • 影响因子:
    12.3
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER S KLEIN其他文献

PETER S KLEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER S KLEIN', 18)}}的其他基金

Molecular mechanisms of lithium action on kinases
锂对激酶作用的分子机制
  • 批准号:
    10705786
  • 财政年份:
    2022
  • 资助金额:
    $ 34.94万
  • 项目类别:
Targeting splicing in myelodysplasia through GSK-3
通过 GSK-3 靶向骨髓增生异常中的剪接
  • 批准号:
    10677505
  • 财政年份:
    2022
  • 资助金额:
    $ 34.94万
  • 项目类别:
Molecular mechanisms of lithium action on kinases
锂对激酶作用的分子机制
  • 批准号:
    10500972
  • 财政年份:
    2022
  • 资助金额:
    $ 34.94万
  • 项目类别:
Targeting Coronavirus through Nucleocapsid Phosphorylation
通过核衣壳磷酸化靶向冠状病毒
  • 批准号:
    10239590
  • 财政年份:
    2021
  • 资助金额:
    $ 34.94万
  • 项目类别:
Maintenance and expansion of long-term hematopoietic stem cells
长期造血干细胞的维持和扩增
  • 批准号:
    9767274
  • 财政年份:
    2018
  • 资助金额:
    $ 34.94万
  • 项目类别:
Maintenance and expansion of long-term hematopoietic stem cells
长期造血干细胞的维持和扩增
  • 批准号:
    10162647
  • 财政年份:
    2018
  • 资助金额:
    $ 34.94万
  • 项目类别:
An unexpected signaling output for the tumor suppressor APC
肿瘤抑制因子 APC 的意外信号输出
  • 批准号:
    9353834
  • 财政年份:
    2016
  • 资助金额:
    $ 34.94万
  • 项目类别:
An unexpected signaling output for the tumor suppressor APC
肿瘤抑制因子 APC 的意外信号输出
  • 批准号:
    9753259
  • 财政年份:
    2016
  • 资助金额:
    $ 34.94万
  • 项目类别:
An unexpected signaling output for the tumor suppressor APC
肿瘤抑制因子 APC 的意外信号输出
  • 批准号:
    9504746
  • 财政年份:
    2016
  • 资助金额:
    $ 34.94万
  • 项目类别:
Regulation of Neurogenesis and Behavior by GSK-3
GSK-3 对神经发生和行为的调节
  • 批准号:
    9001371
  • 财政年份:
    2014
  • 资助金额:
    $ 34.94万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.94万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了